Cancer radiation can safely proceed during COVID-19 pandemic
(HealthDay)—Cancer patients who need radiation therapy shouldn't let fear of COVID-19 delay their treatment, one hospital study suggests.
Aug 27, 2020
0
2
(HealthDay)—Cancer patients who need radiation therapy shouldn't let fear of COVID-19 delay their treatment, one hospital study suggests.
Aug 27, 2020
0
2
Researchers at Karolinska Institutet and Karolinska University Hospital in Sweden have compared the ability of three artificial intelligence (AI) algorithms to identify breast cancer based on previously taken mammograms. ...
Aug 27, 2020
0
1
Robotic surgery for patients with early stage, oropharyngeal squamous cell cancer is associated with improved health outcomes, including better long-term survival, according to a Cedars-Sinai study published Thursday in JAMA ...
Aug 20, 2020
0
7
(HealthDay)—Recent-onset diabetes accompanied by weight loss is associated with a substantially increased risk for developing pancreatic cancer, according to a study published online Aug. 13 in JAMA Oncology.
Aug 18, 2020
0
4
For cancer patients receiving radiation treatment during a surge in COVID-19 cases, adhering to the stay-at-home orders of quarantine is not always an option. The daily hospital trips potentially increase exposure, which ...
Aug 13, 2020
0
33
To impact and improve patient care, the study of artificial intelligence (AI) tools to support screening mammography must now shift from simulated research trials to robust clinical evaluations, according to Constance Lehman, ...
Aug 13, 2020
0
20
When COVID-19 struck, health care pivoted hard. Any unnecessary procedures or appointments were postponed. For people with cancer, that pivot was particularly shattering.
Aug 6, 2020
0
12
Scientists at St. Jude Children's Research Hospital are studying how hearing loss can affect the neurocognitive abilities of childhood cancer survivors. Findings show that survivors with severe hearing loss are at a significant ...
Jul 30, 2020
0
0
A team of researchers from Google Health, working with others from institutions across the U.S. and Canada has found that a Google AI system was able to outperform general pathologists when validating Gleason grading of prostate ...
(HealthDay)—Use of pembrolizumab is supported among patients with advanced melanoma, regardless of BRAF V600E/K mutation status or prior receipt of a BRAF inhibitor (BRAFi) with or without MEK inhibitor (MEKi) therapy, ...
Jul 22, 2020
0
0